5-Hydroxyanthranilic acid structure
|
Common Name | 5-Hydroxyanthranilic acid | ||
---|---|---|---|---|
CAS Number | 394-31-0 | Molecular Weight | 153.14 | |
Density | 1.491 g/cm3 | Boiling Point | 417.8ºC at 760 mmHg | |
Molecular Formula | C7H7NO3 | Melting Point | 247 °C (dec.)(lit.) | |
MSDS | Chinese USA | Flash Point | 206.5ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of 5-Hydroxyanthranilic acid2-Amino-5-hydroxybenzoic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | 5-Hydroxyanthranilic acid |
---|---|
Synonym | More Synonyms |
Description | 2-Amino-5-hydroxybenzoic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog | |
In Vitro | Diabeton 是一种磺酰脲类降血糖药,口服用于治疗非胰岛素依赖型糖尿病。当这种改变本身未被证明有效时,它用于通过饮食改变来补充治疗。它的作用持续时间为12小时或更长时间。老年患者可用糖尿病代替氯磺丙脲。 |
Density | 1.491 g/cm3 |
---|---|
Boiling Point | 417.8ºC at 760 mmHg |
Melting Point | 247 °C (dec.)(lit.) |
Molecular Formula | C7H7NO3 |
Molecular Weight | 153.14 |
Flash Point | 206.5ºC |
Exact Mass | 153.04300 |
PSA | 83.55000 |
LogP | 1.25380 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn:Harmful; |
Risk Phrases | R20/22;R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2918290000 |
Precursor 8 | |
---|---|
DownStream 10 | |
HS Code | 2922509090 |
---|---|
Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Chromatographic evaluation and QSAR optimization for benzoic acid analogues against carbonic anhydrase III.
J. Enzyme Inhib. Med. Chem. 30 , 420-9, (2015) An HPLC-size exclusion method was developed as an assay method to evaluate the binding of tested compounds with carbonic anhydrase III (CAIII) enzyme. Inhibition of CAIII by a group of benzoic acid an... |
|
[The effect of diabeton and metformin on the free-radical oxidation processes and the structural characteristics of the phospholipid composition of the erythrocyte membranes in non-insulin-dependent diabetes mellitus].
Sov. Med. (7) , 14-6, (1991) Newly detected noninsulin--dependent diabetes mellitus is shown to have changes in phospholipid structure of erythrocytic membranes: a fall in total phospholipids, sphingomyelin, phosphatidylcholine, ... |
|
[The efficacy of the antiaggregants ticlid and diabeton in correcting chronic intravascular microcoagulation of the blood in diabetic patients].
Ter. Arkh. 63(10) , 44-9, (1991) Hemocoagulation was examined in 477 diabetes mellitus patients. Whatever the disease type, severity, duration and the intensity of microvascular complications, diabetes mellitus was discovered to be m... |
5-Hydroxyanthranilic |
5-hydroxy-2-aminobenzoic acid |
2-Amino-5-Hydroxybenzoic |
5-hydroxy-2-anthranilic acid |
diabeton |
5-HYDROXYANTHRANILLIC ACID |
MFCD00007870 |
4-aminophenol-2-carboxylic acid |
2-AMINO-5-HYDROXYBENZOIC ACID |
Glyklaside |
Hydroxyanthranilic acid |